StockTrendNews (STN) Exclusive:Progenics Pharmaceuticals, Inc.
x
EBITDA Improves 11.9% for Progenics Pharmaceuticals
Stock Quote:(NGM:PGNX)
11/18/2009
4.49
-0.02
-0.44%
2,190
EBITDA Improves 11.9% for Progenics Pharmaceuticals
Last
Price Change
% Chg
Volume
New York, NY, November 18, 2009-Ebitda News reports that negative EBITDA for Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) for its twelve months ended September 30, 2009 was $(42,703,000), a 11.9% imp ... read full story
Futures fell off their highs in the premarket after the December trade deficit was reported to have widened to $40.2 billion from $36.4 billion in November on a sharp gain in imports. That was much higher than the expected deficit of $36.8 billion. F ... read full story
-0.02 
